bcx9930
bcx9930: 1 clinical trial tracked.
bcx9930 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about bcx9930, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
An Open-label Study to Evaluate the Long-term Safety of BCX9930 Monotherapy in Subjects With Paroxysmal Nocturnal Hemoglobinuria Who Previously Received BCX9930 in a BioCryst-sponsored Study
Primary endpoint: Number of Participants With Treatment-emergent Events (TEAEs)
Interventionalopen28 enrolledStarted 2023-01Completion 2025-0111 sites · France, Hungary, Malaysia, South Africa…BioCryst Pharmaceuticals